Susan Mahony - 27 Feb 2024 Form 4 Insider Report for Axsome Therapeutics, Inc. (AXSM)

Role
Director
Signature
/s/ Nick Pizzie, Attorney-in-Fact
Issuer symbol
AXSM
Transactions as of
27 Feb 2024
Net transactions value
$0
Form type
4
Filing time
29 Feb 2024, 18:18:57 UTC
Previous filing
08 Dec 2023
Next filing
30 May 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXSM Stock Option (Right to Buy) Award $0 +191 $0.000000 191 27 Feb 2024 Common Stock 191 $84.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 191 options elected to be received in lieu of cash compensation earned in 2023. All of such options are immediately exercisable.